Biomarkers

Discover all biomarkers in precision medicine

Loading biomarkers...

Results for "Alpha-fetoprotein"

Target: Alpha-fetoprotein

Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties

Clinical Applications

Down SyndromeHepatocellular CarcinomaNormalRenal Cell CarcinomaHodgkin's diseaseLymphoma

uniprot

Approved Therapies

CYRAMZA (RAMUCIRUMAB) ^[5]

Status: approved

APPROVED

Pipeline Therapies

Characteristics of NAFLD Among Type 2 Diabetes Patients

Ziekenhuis Oost-Limburg

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

PIPELINE

COVID-19 Post-Vaccination Observation

Pachankis, Yang I., M.D.

PIPELINE

Paediatric Hepatic International Tumour Trial

University of Birmingham

PHASE3

Evaluating the Vitamin K2 Status of Calcium-based Stone Formers

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

PIPELINE

Companies Working on Alpha-fetoprotein

Ziekenhuis Oost-Limburg

Non-Alcoholic Fatty Liver Disease

Mayo Clinic

Hepatocellular Carcinoma

Pachankis, Yang I., M.D.

Immune System Diseases

University of Birmingham

Hepatoblastoma

CarboplatinGemcitabineDoxorubicin

TrialsMap

Clinical Intelligence Agent

Interactive Clinical Trials Map

119

United States

Asia

Europe

Other

LitSearch

Scientific Literature Agent

Scientific Publications

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.

PubMedJan 2022

α-fetoprotein-binding toxins and teratogens against cancer.

PubMedJan 2019

The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.

PubMedJan 2018

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.

PubMedNone 2023

High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis.

PubMedFeb 2024

Research Insights

Publication count:

5 papers

Research focus:

Down Syndrome

Sources & References

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.

PubMed•Jan 2022

α-fetoprotein-binding toxins and teratogens against cancer.

PubMed•Jan 2019

The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.

PubMed•Jan 2018

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.

PubMed•None 2023

High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis.

PubMed•Feb 2024

Alpha-fetoprotein - Biomarker

Biomarkers

Results for "Alpha-fetoprotein"

Target: Alpha-fetoprotein

Clinical Applications

Approved Therapies

CYRAMZA (RAMUCIRUMAB) [5]

Pipeline Therapies

Characteristics of NAFLD Among Type 2 Diabetes Patients

Extracellular RNA Markers of Liver Disease and Cancer

COVID-19 Post-Vaccination Observation

Paediatric Hepatic International Tumour Trial

Evaluating the Vitamin K2 Status of Calcium-based Stone Formers

Companies Working on Alpha-fetoprotein

Ziekenhuis Oost-Limburg

Mayo Clinic

Pachankis, Yang I., M.D.

University of Birmingham

TrialsMap

Interactive Clinical Trials Map

LitSearch

Scientific Publications

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.

α-fetoprotein-binding toxins and teratogens against cancer.

The use of alpha-fetoprotein for the treatment of autoimmune diseases and cancer.

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.

High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis.

Research Insights

Sources & References

CYRAMZA (RAMUCIRUMAB) ^[5]